Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.685 USD | +4.07% | -9.90% | +100.37% |
Mar. 20 | Transcript : Trevi Therapeutics, Inc., Q4 2023 Earnings Call, Mar 20, 2024 | |
Mar. 20 | Trevi Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 178M |
---|---|---|---|---|---|
Net income 2024 * | -41M | Net income 2025 * | -53M | EV / Sales 2024 * | - |
Net cash position 2024 * | 116M | Net cash position 2025 * | 199M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.84
x | P/E ratio 2025 * |
-6.07
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.72% |
Latest transcript on Trevi Therapeutics, Inc.
1 day | +4.07% | ||
1 week | -9.90% | ||
Current month | -22.17% | ||
1 month | -17.38% | ||
3 months | +97.43% | ||
6 months | +46.72% | ||
Current year | +100.37% |
Managers | Title | Age | Since |
---|---|---|---|
Jennifer Good
FOU | Founder | 59 | 11-02-28 |
Thomas Sciascia
FOU | Founder | 70 | 10-12-31 |
Lisa Delfini
DFI | Director of Finance/CFO | 54 | 21-08-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anne VanLent
BRD | Director/Board Member | 76 | 18-10-09 |
James Cassella
BRD | Director/Board Member | 69 | 20-02-12 |
Jennifer Good
FOU | Founder | 59 | 11-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +1.04% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 2.685 | +4.07% | 179,001 |
24-04-17 | 2.58 | -3.19% | 249,893 |
24-04-16 | 2.665 | -5.16% | 117,897 |
24-04-15 | 2.81 | -3.77% | 56,947 |
24-04-12 | 2.92 | -2.01% | 93,540 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+100.37% | 178M | |
-3.30% | 102B | |
+1.79% | 96.84B | |
-0.44% | 21.48B | |
-18.35% | 20.82B | |
-7.45% | 18.6B | |
-40.31% | 16.81B | |
-26.84% | 13.78B | |
+0.59% | 13.4B | |
+20.86% | 11.06B |
- Stock Market
- Equities
- TRVI Stock